Alembic Pharma | Business Upturn

Latest Articles

Alembic Pharma gets USFDA final approval for Travoprost Ophthalmic Solution

Corporates · Dec 18, 2025

blank

Alembic Pharma shares rise over 2% after USFDA nod for Diltiazem Hydrochloride Tablets

Stock Market · Nov 17, 2025

blank

Alembic Pharma gets USFDA final nod for Diltiazem Hydrochloride Tablets

Corporates · Nov 15, 2025

blank

Alembic Pharma secures final USFDA approval for Dexlansoprazole DR capsules

Corporates · Nov 13, 2025

blank

Alembic Pharma shares rally sharply over 6% as Q2 net profit jumps 21% YoY to Rs 185 crore, revenue up 16%

Stock Market · Nov 4, 2025

blank

Alembic Pharma Q2 Results: Revenue jumps 16% YoY to Rs 1,910 crore, net profit up 21%

Quarterly Results · Nov 4, 2025

blank

Alembic Pharma receives USFDA final approval for Phytonadione Injectable Emulsion USP

Corporates · Sep 9, 2025

blank

Alembic Pharma gets USFDA nod for Carbamazepine Extended-Release Tablets

Corporates · Jul 26, 2025

blank

Alembic Pharma acquires UK-based Utility Therapeutics for $12 million to expand US presence

Corporates · Jul 3, 2025

blank

Alembic Pharma share jump 11% after company gets US FDA approval for Doxorubicin Hydrochloride Injection

Stock Market · Jun 30, 2025

blank

Alembic Pharma receives EIR from USFDA for Karakhadi API-III facility

Corporates · Jun 18, 2025

blank

Alembic Pharma shares dip over 2% after USFDA issues 4 observations for Panelav facility

Stock Market · Jun 2, 2025

blank

Alembic Pharma share price jumps 3% after USFDA issues EIR from for Panelav plant

Stock Market · Apr 30, 2025

blank

Alembic Pharma shares drop 2.6% after US FDA issues one observation for Vadodara unit

Stock Market · Mar 10, 2025

blank

Alembic Pharma Q2 FY25 Results: Revenue jumps 3.3% YoY to ₹1,647.98 crore, net profit jumps 12.2% YoY

Stock Market · Nov 7, 2024

By Aditya Bhagchandani

Showing 15 of 18 articles